XML 33 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
STATEMENT OF CONSOLIDATED OPERATIONS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
REVENUES AND OTHER:      
Derivative instrument gains (losses), net $ 0 $ (107) $ 94
Gain on divestitures, net 8 1,180 67
Losses on previously sold Gulf of Mexico properties (212) (157) (446)
Other, net 26 139 228
Total revenues and other 7,795 11,938 7,928
OPERATING EXPENSES:      
Lease operating expenses [1] 1,397 1,435 1,241
Taxes other than income 192 256 204
Exploration 153 146 127
General and administrative 325 462 357
Transaction, reorganization, and separation 15 26 22
Depreciation, depletion, and amortization 1,399 1,177 1,360
Asset retirement obligation accretion 116 117 113
Impairments 61 0 208
Financing costs, net 165 313 472
Total operating expenses 4,879 6,064 5,948
NET INCOME BEFORE INCOME TAXES 2,916 5,874 1,980
Current income tax provision 1,338 1,507 652
Deferred income tax provision (benefit) (1,652) 145 (74)
NET INCOME INCLUDING NONCONTROLLING INTERESTS 3,230 4,222 1,402
Net income (loss) attributable to Altus Preferred Unit limited partners 0 (70) 162
NET INCOME ATTRIBUTABLE TO APACHE CORPORATION 2,526 3,536 1,062
Noncontrolling Interest - Sinopec      
OPERATING EXPENSES:      
Net income attributable to noncontrolling interest 352 464 174
Noncontrolling interest - Altus      
OPERATING EXPENSES:      
Net income attributable to noncontrolling interest 0 14 4
Noncontrolling Interest - APA Corporation      
OPERATING EXPENSES:      
Net income attributable to noncontrolling interest 352 278 0
Oil and gas      
REVENUES AND OTHER:      
Total revenues 7,973 10,883 7,985
Gathering, processing, and transmission costs      
REVENUES AND OTHER:      
Total revenues [1] 7,079 9,028 6,498
OPERATING EXPENSES:      
Cost of goods and services sold [1] 314 356 264
Purchased oil and gas sales      
REVENUES AND OTHER:      
Total revenues [1] 894 1,855 1,487
OPERATING EXPENSES:      
Cost of goods and services sold [1] $ 742 $ 1,776 $ 1,580
[1]
(1) For related party transactions associated with Kinetik, refer to Note 7—Equity Method Interest for further detail.